Related Experiment Video
Updated: Mar 7, 2026

Isolation and Characterization of Neutrophils with Anti-Tumor Properties
Published on: June 19, 2015
A myeloid tumor suppressor role for NOL3
Robert F Stanley1, Richard T Piszczatowski1, Boris Bartholdy1
1Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461.
Abstract:
Despite the identification of several oncogenic driver mutations leading to constitutive JAK-STAT activation, the cellular and molecular biology of myeloproliferative neoplasms (MPN) remains incompletely understood. Recent discoveries have identified underlying disease-modifying molecular aberrations contributing to disease initiation and progression. Here, we report that deletion of Nol3 (Nucleolar protein 3) in mice leads to an MPN resembling primary myelofibrosis (PMF). Nol3 MPN mice harbor an expanded Thy1+LSK stem cell population exhibiting increased cell cycling and a myelomonocytic differentiation bias. Molecularly, this phenotype is mediated by Nol3-/--induced JAK-STAT activation and downstream activation of cyclin-dependent kinase 6 (Cdk6) and MycNol3 MPN Thy1+LSK cells share significant molecular similarities with primary CD34+ cells from PMF patients. NOL3 levels are decreased in CD34+ cells from PMF patients, and the NOL3 locus is deleted in a subset of patients with myeloid malignancies. Our results reveal a novel genetic PMF-like mouse model and identify a tumor suppressor role for NOL3 in the pathogenesis of myeloid malignancies.
Insights
Deletion of Nucleolar protein 3 (Nol3) in mice causes myeloproliferative neoplasms (MPN) similar to primary myelofibrosis (PMF). This study identifies Nol3 as a tumor suppressor in myeloid malignancies.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Myeloproliferative neoplasms (MPN) pathogenesis is not fully understood despite known JAK-STAT pathway mutations.
- Recent research highlights molecular aberrations in MPN initiation and progression.
Purpose of the Study:
- To investigate the role of Nucleolar protein 3 (Nol3) in MPN development.
- To establish a novel genetic mouse model for primary myelofibrosis (PMF).
Main Methods:
- Generated a mouse model with Nol3 deletion (Nol3-/-) to study MPN.
- Analyzed stem cell populations (Thy1+LSK) for cell cycling and differentiation.
- Assessed JAK-STAT pathway activation and downstream targets (Cdk6, Myc).
- Compared molecular profiles of mouse MPN cells with human PMF patient samples.
Main Results:
- Nol3 deletion in mice induced an MPN resembling PMF.
- Nol3-/- mice exhibited expanded Thy1+LSK stem cells with increased cycling and myelomonocytic bias.
- Phenotype was driven by Nol3-/- induced JAK-STAT activation, leading to Cdk6 and Myc upregulation.
- Nol3 MPN cells showed molecular similarities to human PMF CD34+ cells.
- Decreased NOL3 levels and locus deletion were observed in PMF patients.
Conclusions:
- Nol3 deletion drives a PMF-like MPN through JAK-STAT pathway activation.
- Nol3 acts as a tumor suppressor in myeloid malignancies.
- Identified a novel genetic mouse model for PMF research and revealed Nol3's role in disease pathogenesis.
Related Concept Videos
Abnormal Proliferation
Differentiation of Common Myeloid Progenitor Cells
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Regulation of Hematopoietic Stem Cells

